2015, Anxiety disorders and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2015

Anxiety disorders

Pharmaceuticals

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

MARCH 15, 2025

There is no more important institution in establishment psychiatry than the National Institute of Mental Health (NIMH), and in 2022, psychiatrist Thomas Insel, NIMH director from 2002-2015, stated in his book Healing , The idea of mental illness as a chemical imbalance has now given way to mental illnesses as connectional or brain circuit disorders.

Neurotransmitters and mental health

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals

Default Depression—How We Now Interpret Distress as Mental Illness

Mad in America

FEBRUARY 1, 2025

R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxiety disorder. This process of medicalisation is now all too often a default response to distress and happens on a large scale.

Aging and mental health

Aging and mental health Insurance Mental health policy Pharmaceuticals

Mental Health Clinicians

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Default Depression—How We Now Interpret Distress as Mental Illness

Stay Connected